{"product_id":"lung-pathology-masters-of-pathology","title":"Lung Pathology – Masters of Pathology Series 2019","description":"\u003ch3\u003eLung Pathology – Masters of Pathology Series 2019\u003c\/h3\u003e\u003cbr\u003eLung Pathology – Masters of Pathology Series 2019 (CME Videos) A broad approach to key topics in thoracic pathology with special focus on its implications in lung cancer diagnosis and treatment. Includes video microscopy sessions.\u003cbr\u003e\u003cbr\u003eStay Current with the Latest Key Advances\u003cbr\u003e\u003cbr\u003eThrough engaging lectures, case studies, and virtual microscopy sessions, Masters of Pathology Series – Lung Pathology helps build and translate knowledge into realistic diagnostic scenarios. Course Director Lynette M. Sholl, MD, and her colleagues deliver in-depth coverage of topics like granulomatous diseases, vasculitis, multiple lung tumors, lung transplant pathology, pulmonary vascular pathology, benign mimics of lung cancer, and more. This CME course will help you to better:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eRecognize common, uncommon mediastinal tumors including thymic neoplasms\u003c\/li\u003e\n\u003cli\u003eInterpret the clinical implications of specific carcinoma diagnoses\u003c\/li\u003e\n\u003cli\u003eIdentify effective diagnostic and predictive biomarkers for NSCLC diagnosis\u003c\/li\u003e\n\u003cli\u003eDifferentiate between reactive and neoplastic proliferations of the lung and pleura\u003c\/li\u003e\n\u003cli\u003eUnderstand the relevance of IHC, FISH, molecular tests for diagnosing malignant mesothelioma\u003c\/li\u003e\n\u003cli\u003eDefine appropriate biomarkers to select lung cancer patients for immunotherapy\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\u003cbr\u003eAt the conclusion of this course, the participant will be able to do the following:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eIdentify the pathologic and immunohistochemical features of common lung carcinomas and understand the clinical implications of specific carcinoma diagnoses\u003c\/li\u003e\n\u003cli\u003eIdentify the crucial diagnostic and predictive biomarkers for non-small cell lung carcinomas and understand how to apply them in clinical practice\u003c\/li\u003e\n\u003cli\u003eDefine appropriate biomarkers for selection of lung cancer patients for immunotherapy\u003c\/li\u003e\n\u003cli\u003eDistinguish between reactive and neoplastic proliferations of the lung and pleura\u003c\/li\u003e\n\u003cli\u003eClassify correctly primary and metastatic mimics of non-small cell lung carcinomas\u003c\/li\u003e\n\u003cli\u003eRecognize common and uncommon mediastinal tumors including thymic neoplasms\u003c\/li\u003e\n\u003cli\u003eRecognize clinically significant interstitial changes in the lung in patients with and without prospectively recognized clinical and radiographic correlates\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eIntended Audience\u003c\/h3\u003e\u003cbr\u003eThis educational activity was designed for practicing pathologists, oncologists, pulmonologists, and pathology assistants.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003ch3\u003eTOPICS\/SPEAKERS\u003c\/h3\u003e\n\u003ch3\u003ePleura\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eMesothelioma – Marina Vivero, MD\u003c\/li\u003e\n\u003cli\u003eLymphohistiocytic Neoplasms of the Lung and Pleura and their Differential – A Pulmonary Pathologist’s Perspective – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eMediastinum\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eThymic Pathology: Hyperplasia, Thymoma, and Neuroendocrine Tumors – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003cli\u003eThymic Carcinoma and other Anterior Mediastinal Malignancies – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eNeuroendocrine Tumors\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eTypical and Atypical Carcinoid and Precursor Lesions – Marina Vivero, MD\u003c\/li\u003e\n\u003cli\u003eHigh Grade Neuroendocrine Carcinomas of the Lung – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eNon-Small Cell Lung Carcinomas\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eClinical and Pathologic Features of Pulmonary Squamous Cell Carcinoma – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003cli\u003eClinical and Pathologic Features of Adenocarcinoma of the Lung – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003cli\u003eLepidic-Predominant Tumors: Rules for Classification and Implications for Staging – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003cli\u003ePoorly Differentiated and Undifferentiated Tumors of the Lung – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003cli\u003eBenign Mimics of Lung Cancer – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eImmunohistochemistry for Lung Cancer\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eImmunohistochemistry for Lung Carcinomas: Diagnosis – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003cli\u003eImmunohistochemistry for Lung Cancer: Prediction – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eBiomarkers in Lung Cancer\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eGenomic Biomarkers for Non Small Cell Lung Carcinoma – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003cli\u003eOverview of Immunotherapy Biomarkers for NSCLC – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eInterstitial Lung Diseases\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eInterstitial Lung Disease Pathology – Robert F. Padera, Jr., MD, PhD\u003c\/li\u003e\n\u003cli\u003eGranulomatous Diseases – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003cli\u003eMicroscopy Session: Infectious Diseases – Robert F. Padera, Jr., MD, PhD\u003c\/li\u003e\n\u003cli\u003eConnective Tissue Disease – Interstitial Lung Disease – Marina Vivero, MD\u003c\/li\u003e\n\u003cli\u003eLung Transplant Pathology – Robert F. Padera, Jr., MD, PhD\u003c\/li\u003e\n\u003cli\u003eSmoking – Related Lung Diseases – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003cli\u003ePulmonary Vascular Pathology – Robert F. Padera, Jr., MD, PhD\u003c\/li\u003e\n\u003cli\u003eVasculitis – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSurvival Sessions\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eManaging Small Biopsies for Lung Cancer – Specimen Handling for Optimal Diagnostic and Predictive Testing – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003cli\u003eMicroscopy Session: Interpretation of PD-L1 Immunohistochemistry – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003cli\u003eAtypical Epithelial Proliferation in the Lung: Is It Reactive or Neoplastic? – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003cli\u003eMultiple Lung Tumors: Same or Different? – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003cli\u003ePotpourri of Pulmonary Problems: Special T, N, M Challenges in Lung Cancer Pathology – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003cli\u003eMicroscopy Session: Cytology of Lung Cancers – Marina Vivero, MD\u003c\/li\u003e\n\u003cli\u003eReactive Pleuritis vs. Mesothelioma – Making the Distinction – Lynette M. Sholl, MD\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eDate of Original Release: June 1, 2019\u003cbr\u003e\u003cbr\u003eDate Credits Expire: June 1, 2022\u003cbr\u003eEstimated Time to Complete: 15.75 hours\u003cbr\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954308223074,"sku":"MED-AMB00904","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/0002095_lung-pathology_300.jpg?v=1779370826","url":"https:\/\/meducourse.com\/products\/lung-pathology-masters-of-pathology","provider":"Meducourse","version":"1.0","type":"link"}